Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease

NCT00632359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Lenalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]